● Recruiting

Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.

Condition: Venous Leg Ulcer · Venous Leg · Diabetic Foot · Sponsor: Tiger Biosciences, LLC.

PhasePhase 4

Planned participants340

Who can joinAll sexes, 21 Years to no upper limit

Healthy volunteersNo

About this study

Title A Multicenter, Prospective, Randomized Controlled Modified Multi-Platform (Matriarch) Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care versus Standard of Care alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.

This description comes directly from the study's public registry record.

Talk to the study team

Arshdeep Kaur, MS · 1-888-665-5005 · arshdeep.kaur@sientra.com

Madison Dunn · mdunn@serenagroups.com

Always discuss trial participation with your own doctor first.

Locations (1)

Serena Group

Monroeville, Pennsylvania, United States

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06826339